4//SEC Filing
Fleming Harold Edward 4
Accession 0002036042-25-000029
CIK 0002036042other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:07 PM ET
Size
5.7 KB
Accession
0002036042-25-000029
Insider Transaction Report
Form 4
Fleming Harold Edward
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-12+19,959→ 19,959 totalExercise: $16.99Exp: 2035-06-11→ Common Stock (19,959 underlying)
Footnotes (2)
- [F1]The Reporting Person has agreed to receive and hold for the benefit of Enavate Sciences, LP, any securities granted to him for his service as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the option and the shares issuable upon exercise thereof.
- [F2]This option vests in full upon the earlier of June 12, 2026 or the date of the next annual meeting of Sionna Therapeutics, Inc., subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Sionna Therapeutics, Inc.
CIK 0002036042
Entity typeother
Related Parties
1- filerCIK 0001857250
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:07 PM ET
- Size
- 5.7 KB